August Pi Sunyer Biomedical Research Institute
5
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort
Role: collaborator
Primary Care-based Facilitated Access to a Web Based Brief Intervention to Reduce Alcohol Consumption
Role: collaborator
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:
Role: collaborator
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control
Role: collaborator
Impact of Obstructive Sleep Apnea Syndrome on Metabolic Syndrome in Severe Obesity
Role: collaborator
All 5 trials loaded